← All trials
NCT06940921
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 20, 2025
- Primary completion
- Nov 30, 2027
- Completion date
- Nov 30, 2027
- First posted
- Apr 23, 2025
- Last posted
- Apr 27, 2025
- Enrollment
- 26
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Chongqing Medical UniversityLead sponsor
- Akeso Pharmaceuticals, Inc.Collaborator
- Chongqing Medical UniversityOfficial
- Chongqing Medical UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.